Podcast: How China is rewriting the rules of AI healthcare with Dr. Ruby Wang

Treść źródłowa

Watch or listen to the High Capacity podcast on:YouTubeApple PodcastsSpotifyChina’s biotech and healthcare sectors are evolving at extraordinary speed — from AI-powered “doctor avatars” and digital health super apps to a wave of Chinese drug innovation reshaping the global pharmaceutical industry.In this episode, I speak with physician and healthcare strategist Dr. Ruby Wang about the latest trends in China’s AI + healthcare innovation.Ruby Wang is a UK-trained physician, founder of China Health Pulse, and author of the upcoming book China Cure, which explores the global impact of China’s biotech and AI healthcare advances.Links:China Health Pulse newsletter and podcastTranscriptKyle Chan (00:00)Welcome to the High Capacity Podcast. I’m your host, Kyle Chan, a fellow at Brookings. I’m thrilled to be joined today by my guest, Dr. Ruby Wang, a UK-trained physician and founder of LINTRIS Health, a strategy consultancy. She runs the amazing China Health Pulse newsletter and podcast on healthcare and technology in China, which I highly recommend. She also has a book coming out in October titled China Cure, which describes the global impact of China’s biotech and AI health advances. Welcome, Ruby, and thanks for coming on the show.Ruby Wang (00:34)Thanks so much for having me, Kyle. It’s such an honor. I’m a huge fan of High Capacity. We’ve been Substack friends for a while, so it’s great to come on here. I’m excited to chat.Kyle Chan (00:42)That’s right.I’m really happy to have you on. You just came back from a more than month-long trip in China, where you were looking at a numb…